Pith. sign in

REVIEW 5 major objections 5 minor 97 references

A Bioinformatic Study of Genetics Involved in Determining Mild Traumatic Brain Injury Severity and Recovery

T0 review · 5 major / 5 minor · reviewed 2026-08-16 · deepseek-v4-flash

Pith's one-line read Circulating microRNA hsa-miR-10a-5p rises after mild head injury and may serve as a blood-based biomarker of severity and recovery.

desk verdict A competent hypothesis-generating bioinformatics screen whose central miRNA claim is undercut by the uncontrolled MMA dataset; worth a serious referee but only as a candidate list. read the letter →

arxiv 2505.00572 v1 pith:WK65NJ7F submitted 2025-05-01 q-bio.GN q-bio.NC

classification q-bio.GNq-bio.NC
keywords mildtraumaticbraininjurymicroRNAbiomarkerhsa-miR-10a-5phubgenessequencinganalysisbioinformaticssynapticplasticity
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper argues that a small set of genes and microRNAs, led by hsa-miR-10a-5p, tracks the severity and recovery of mild traumatic brain injury. Using public databases and a serum RNA-sequencing dataset from amateur mixed martial arts fighters, it identifies 11 hub genes engaged in neuron projection regeneration and synaptic plasticity, plus 8 miRNAs predicted to regulate them. It then finds 17 miRNAs significantly changed immediately after injury, with hsa-miR-10a-5p strongly upregulated, and links hsa-miR-10b-5p and hsa-miR-143-3p to the number of head hits. If correct, these molecules would be priority candidates for non-invasive diagnostic and prognostic tests for mTBI.

What carries the argument

The load-bearing object is the predicted regulatory network linking the 11 hub genes to eight miRNAs: hsa-miR-9-5p, hsa-miR-204-5p, hsa-miR-1908-5p, hsa-miR-16-5p, hsa-miR-10a-5p, hsa-miR-218-5p, hsa-miR-34a-5p, and hsa-miR-199b-5p. The hub genes were selected from 129 candidates by functional enrichment, protein-protein interaction topology, and exclusion of brain-only and inflammatory genes; the miRNAs were kept only if multiple prediction tools agreed. This network then anchors the interpretation of differential expression in serum after acute injury, connecting observed miRNA rises to biological processes of neuronal repair.

What would settle it

Collect serum from a cohort with extracranial injuries (for example orthopedic trauma) and from athletes after intense exercise without head impacts, then measure hsa-miR-10a-5p, hsa-miR-10b-5p, and hsa-miR-143-3p. If these miRNAs rise in either control group to levels seen after mixed martial arts bouts, the mTBI-specific biomarker claim fails.

Watch

Extended reading notes

Core claim

The paper's central claim is that specific genes and miRNAs, particularly hsa-miR-10a-5p, influence mild traumatic brain injury outcomes and that measuring them in blood could help diagnose injury and forecast recovery. The supporting argument is built from an 11-gene hub set: APOE, S100B, GFAP, BDNF, AQP4, COMT, MBP, UCHL1, DRD2, ASIC1, and CACNA1A, whose functional enrichment converges on neuron projection regeneration and synaptic plasticity. Eight miRNAs predicted to target these genes were identified, and in the serum dataset 17 miRNAs changed significantly at 0 and 2-3 days post-injury, with hsa-miR-10a-5p among the most strongly elevated immediately after injury. The paper also reports that hsa-miR-10b-5p and hsa-miR-143-3p levels correlate positively with the number of direct head hits, making them candidate markers of injury load.

Load-bearing premise

The serum miRNA changes measured in mixed martial artists after a bout are due to mild brain injury rather than to exercise, physiological stress, or extracranial trauma; the dataset had no non-head-injury control group.

Editorial extensions

If this is right

  • Blood levels of the 17 acutely changed miRNAs, especially hsa-miR-10a-5p, could become a diagnostic readout for recent mild head injury.
  • The relationship of hsa-miR-10b-5p and hsa-miR-143-3p with number of head hits could provide a molecular measure of mechanical injury load.
  • The 11-gene network centered on neuron projection regeneration and synaptic plasticity could nominate repair pathways for therapeutic targeting.
  • The apparent normalization of miRNA levels by one week after injury implies the blood biomarker window is acute, limiting its use for retrospective diagnosis.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • A prospective study adding an orthopedic-trauma control group would directly test whether hsa-miR-10a-5p is brain-specific rather than a general tissue-damage marker; such a design is the natural next step.
  • The dopaminergic synapse enrichment suggests the same miRNA set may be altered in non-traumatic conditions such as depression or Parkinson's disease, so cross-disorder serum profiling would clarify what is mTBI-specific.
  • Because the fighter dataset cannot separate concussion from cumulative subconcussive hits, an experiment measuring these miRNAs after controlled soccer heading without diagnosed concussion would test whether subconcussive impacts alone trigger the same rises.
  • Single-cell transcriptomic data from injured cortex could reveal whether hsa-miR-10a-5p and BDNF are co-expressed in regenerating projection neurons, giving mechanistic support to the predicted regulatory link.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

5 major / 5 minor

Summary. This in silico study aims to identify genes and miRNAs associated with mild traumatic brain injury (mTBI) severity and recovery. The authors compile candidate genes from NCBI Gene, MalaCards, and their own prior literature review, reduce the list to 11 hub genes through enrichment and protein-protein interaction analyses, predict eight putatively regulatory miRNAs using several target-prediction tools, and then analyze the public RNA-seq dataset GSE123336 (serum miRNAs from MMA fighters) to look for differential expression after head injury. They report that 17 miRNAs are significantly changed at day 0 and again at 2–3 days post-injury, highlight hsa-miR-10a-5p as particularly relevant, and note that hsa-miR-10b-5p and hsa-miR-143-3p correlate with the number of head hits. The abstract concludes that these genes and miRNAs, particularly hsa-miR-10a-5p, may guide future mTBI diagnostics.

Significance. If the central claim held, the proposed 11-gene/8-miRNA network and the specific serum miRNA hsa-miR-10a-5p would be plausible priority candidates for prospective mTBI biomarker validation. The study has some strengths: it uses publicly available high-throughput data, applies explicit significance thresholds, reports exact p-values, and transparently acknowledges the absence of a control group for circulating biomarkers. However, the current evidence is hypothesis-generating rather than confirmatory. The main analytical pipeline is largely reproducible in principle, although the authors state that code and analysis details are only available on request, and the overlap between the predicted miRNA list and the RNA-seq results is very small. The potential clinical significance is real but conditional on overcoming the confounding and circularity concerns detailed below.

major comments (5)
  1. [Results, 'Identification of Differential Expression miRNAs in GSE123336'; Discussion, Limitations] The central inference that hsa-miR-10a-5p is an mTBI biomarker is confounded by the design of GSE123336. In the RNA-seq analysis, 0-day post-injury samples are compared with each fighter's pre-injury baseline (Methods, 'RNA-sequencing Analysis'), but an mTBI is perfectly confounded with the acute physiological stress of an MMA bout, including exhaustive exercise, psychological stress, and possible extracranial trauma. The authors themselves acknowledge in the Discussion that no control group was included and that extracranial injury controls would be needed to establish specificity. Given this acknowledged limitation, the abstract's statement that 'specific genes and miRNAs, particularly hsa-miR-10a-5p, may influence mTBI outcomes' and the framing of hsa-miR-10a-5p as a diagnostic candidate overstate what this design can support. The authors should either provide external validation with a non-head-injury control or explicitly reframe the conclusion as a hypothesis-generation result rather than a biomarker claim.
  2. [Methods, 'Data Analysis: Functional Enrichment and Pathway Analysis'; Results, 'Identifying Candidate Genes Using…] The reduction from 129 genes to 11 candidate genes is circular with respect to the reported enrichment results. Genes were selected using inclusion criteria that explicitly require 'functional similarity to established mTBI-related pathways' and involvement in 'neuroinflammation, neuronal repair, and synaptic plasticity' (Methods), and genes expressed only in brain tissue, inflammatory genes, and cytokines were then excluded post hoc. It is therefore not surprising that the final 11 genes are enriched for neuron projection regeneration and synaptic plasticity; the enrichment is partly guaranteed by the selection procedure. Furthermore, Table 1's top biological process, neuron projection regeneration, is based on only 2 of the 11 genes (count = 2) with a p-value of 4.80E-03 that is not corrected for the number of GO terms tested. The authors should present an unbiased gene-selection procedure, use a background-matched enrichment test, or explicitly state that the enrichment is a descriptive property of a curated list rather than independent evidence.
  3. [Results, 'miRNA-Target Analysis'; Table 3; Table 4] The claimed validation of predicted miRNAs by RNA-seq rests on a single overlapping miRNA. Of the eight predicted miRNAs listed in Table 3, only hsa-miR-10a-5p appears among the 17 differentially expressed miRNAs in Table 4. The two miRNAs highlighted for their correlation with head hits, hsa-miR-10b-5p and hsa-miR-143-3p, are not in the predicted miRNA set. The manuscript does not provide an intersection analysis, an expected-overlap calculation, or any adjustment for testing the overlap between an 8-miRNA prediction set and a 17-miRNA DE set. As a result, the 'comparison with our miRNA predictions' is at most a single concordant observation, and the text should quantify this overlap and temper the claim that the RNA-seq analysis validates the predicted miRNA panel.
  4. [Methods, 'Data Processing'; Results, 'Identification of Differential Expression miRNAs in GSE123336'; Table 4] The statistical reporting is internally inconsistent and incomplete. The Methods state that a P-adjusted value threshold of ≤ 0.05 was used and then say a Bonferroni correction was applied, but DESeq2's default 'padj' is the Benjamini-Hochberg FDR, not a Bonferroni correction. If a custom Bonferroni correction was applied, the parameters are not described and the code is not deposited. In addition, the text says 17 miRNAs were significantly changed at both 0 days and 2–3 days post-injury, but Table 4 lists results only for the 0-day comparison, and no table or supplementary file gives the 2–3 day p-values and directions of change. The authors should clarify which multiple-testing correction was actually used and provide the full 2–3 day results.
  5. [Results, 'Identification of Differential Expression miRNAs in GSE123336'] The claim that hsa-miR-10b-5p and hsa-miR-143-3p 'were positively correlated with direct head hits' is not supported by any reported correlation coefficient, confidence interval, or statistical test. The text provides only adjusted p-values for a comparison between participants with more than 20 head hits and other participants. A comparison of groups is not itself a correlation, and the number of head hits is also likely to correlate with fight intensity, physical exertion, and total trauma burden. The authors should report the actual correlation analysis or reframe the statement as a group comparison, and they should acknowledge that this association is not specific to head trauma.
minor comments (5)
  1. [Abstract; Results, 'miRNA-Target Analysis'] Several miRNA names are misspelled as 'has-miR-218-5p', 'has-miR-34a-5p', and 'has-miR-199b-5p'; these should be corrected to 'hsa-miR-' throughout the manuscript.
  2. [Methods, 'Data Processing'] The statement 'The coding and analysis details are available upon request' (Data Availability) is not sufficient for reproducibility; the authors should deposit the analysis scripts and parameter settings in a public repository.
  3. [Table 2] The table headers contain spelling errors: 'GOBP_SYNSPTIC_SIGNALING' should be 'GOBP_SYNAPTIC_SIGNALING', and 'HP_COGNITTIVE_IMPAIRMENT' should be 'HP_COGNITIVE_IMPAIRMENT'.
  4. [Results, 'Identification of Differential Expression miRNAs in GSE123336'] The sentence ending '...hsa-miR-143-3p (Padj =0.0082) (Figure 7In terms of GO and pathway analysis...' is missing a period and a space; it should read 'Figure 7. In terms of GO and pathway analysis...'.
  5. [Discussion] The sentence beginning 'Lastly, for future studies, integrating bulk RNA-seq with single-cell transcriptomics...' introduces DLK inhibition and ATF3 modulation without a connecting explanation; the relevance to the preceding miRNA discussion should be clarified or the sentence shortened.

Circularity Check

1 steps flagged · score 2.0 of 10

Minor self-definitional gene filtering; the miRNA biomarker claim is supported by independent external RNA-seq data.

  1. self definitional [Methods, gene selection criteria (pp. 8-9); Results, 'Identifying Candidate Genes' (p. 15)]
    "Inclusion criteria for gene selection were based on the following: (1) functional similarity to established mTBI-related pathways (such as neuroinflammation, neuronal repair, and synaptic plasticity); (2) involvement in pertinent biological processes (identified through gene ontology terms associated with inflammation, glial activity, cognition, and axonal repair); and (3) their purported influence on mTBI outcomes (such as functional recovery, cognitive impairment, and long-term neurological effects)."

    The 11 'candidate hub genes associated with mTBI outcome' are the output of a filter whose input already required 'purported influence on mTBI outcomes' and functional similarity to mTBI-related pathways; the later enrichment in neuron projection regeneration and synaptic plasticity is therefore partly guaranteed by the selection criteria rather than independently discovered. This is a minor circularity because the paper's central biomarker claim, especially hsa-miR-10a-5p, rests on miRNA target predictions from independent databases and on differential expression in the external GSE123336 dataset, not on this gene filter alone.

full rationale

The central derivation is largely self-contained. Candidate genes were curated from public databases (NCBI Gene, MalaCards) plus literature, and the 11-gene list is a data-filtering outcome rather than a fitted parameter. The miRNA predictions came from independent target-prediction tools (miRSystem, miRWalk2.0, mirDIP), and the RNA-seq analysis of GSE123336 is external public data processed with standard tools (BWA, featureCounts, DESeq2); the overlap between predicted hsa-miR-10a-5p and its observed upregulation is a genuine independent convergence, not a constructed identity. The one mildly circular element is the gene-selection step, where inclusion criteria already specified mTBI-outcome influence and mTBI-related pathways, so reporting these genes as outcome-associated is partly a restatement of the filter. Separately, the Discussion explicitly concedes the absence of an extracranial-injury control group: 'We were unable to include a control group for circulating biomarkers... Introducing controls from patients with extracranial injuries... would help determine whether extracranial injuries impact the levels of candidate miRNAs.' That is a confound/validity limitation for causal attribution of the serum miRNA changes to mTBI, not a circularity, and it does not reduce any equation's output to its input. No load-bearing self-citation chain or uniqueness import is present; the citation of the authors' prior review (ref 46) is one of several inputs and is not what forces the miRNA conclusion.

Assumptions & free parameters 3 free parameters · 5 assumptions · 0 invented entities

No fitted constants are derived from data, but several hand-chosen thresholds shape the final gene and miRNA lists. The main axioms are database accuracy, target-prediction reliability, and the mTBI-specificity of the MMA serum cohort. No new molecular entities are introduced; all candidates are existing genes and miRNAs.

free parameters (3)
  • STRING confidence threshold = 0.4
    Medium-confidence PPI edge cutoff; changes hub gene ranking and the top-10 list.
  • miRNA prediction overlap thresholds = miRSystem hit >=1; miRWalk >=3 of 12 databases
    These hand-picked cutoffs determine which of the many predicted miRNAs survive to the final 8.
  • Significance threshold for RNA-seq = Padj <= 0.05 after Bonferroni correction
    Standard but arbitrary; determines the 17 DE miRNAs and the headline list.
assumptions (5)
  • domain assumption Gene and MalaCards database annotations and gene weights accurately reflect mTBI-relevant genes.
    Used to narrow 129 candidate genes to 11; noisy annotations would bias the candidate list.
  • domain assumption miRNA target prediction tools such as miRSystem, miRWalk, and mirDIP provide true miRNA-mRNA regulatory interactions.
    The 8 predicted miRNAs are selected from these databases without experimental validation of binding or function.
  • domain assumption Serum miRNA changes in MMA fighters around competitions represent mTBI-specific molecular responses.
    There is no non-head-injury control group, so exercise, stress, or extracranial trauma could confound the observed changes; acknowledged in limitations.
  • domain assumption DESeq2 negative binomial assumptions and hg38/miRBase alignment recover true miRNA counts.
    The differential expression results depend on this pipeline, but no QC metrics or code are provided.
  • domain assumption The large sample drop at later time points is ignorable.
    One-week post-injury has only 3 samples; no sensitivity analysis or missing-data adjustment is reported.

how reviews work

0 comments
Cite this review

Pith. "Pith review of A Bioinformatic Study of Genetics Involved in Determining Mild Traumatic Brain Injury Severity and Recovery." pith.science (2026). https://pith.science/paper/WK65NJ7F

@misc{pith2026250500572,
  author       = {Pith},
  title        = {Pith review of: A Bioinformatic Study of Genetics Involved in Determining Mild Traumatic Brain Injury Severity and Recovery},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/WK65NJ7F}},
  note         = {Machine review of arXiv:2505.00572}
}
read the original abstract

Aim: This in silico study sought to identify specific biomarkers for mild traumatic brain injury (mTBI) through the analysis of publicly available gene and miRNA databases, hypothesizing their influence on neuronal structure, axonal integrity, and regeneration. Methods: This study implemented a three-step process: (1) Data searching for mTBI-related genes in Gene and MalaCard databases and literature review ; (2) Data analysis involved performing functional annotation through GO and KEGG, identifying hub genes using Cytoscape, mapping protein-protein interactions via DAVID and STRING, and predicting miRNA targets using miRSystem, miRWalk2.0, and mirDIP (3) RNA-sequencing analysis applied to the mTBI dataset GSE123336. Results: Eleven candidate hub genes associated with mTBI outcome were identified: APOE, S100B, GFAP, BDNF, AQP4, COMT, MBP, UCHL1, DRD2, ASIC1, and CACNA1A. Enrichment analysis linked these genes to neuron projection regeneration and synaptic plasticity. miRNAs linked to the mTBI candidate genes were hsa-miR-9-5p, hsa-miR-204-5p, hsa-miR-1908-5p, hsa-miR-16-5p, hsa-miR-10a-5p, has-miR-218-5p, has-miR-34a-5p, and has-miR-199b-5p. The RNA sequencing revealed 2664 differentially expressed miRNAs post-mTBI, with 17 showing significant changes at the time of injury and 48 hours post-injury. Two miRNAs were positively correlated with direct head hits. Conclusion: Our study indicates that specific genes and miRNAs, particularly hsa-miR-10a-5p, may influence mTBI outcomes. Our research may guide future mTBI diagnostics, emphasizing the need to measure and track these specific genes and miRNAs in diverse cohorts.

Figures

Figures reproduced from arXiv: 2505.00572 by the authors.

Figure 1
Figure 1. Step one of the methodologies was to explore mTBI related genes in the databases (Gene database from National Center for Biotechnology Information (NCBI) and MalaCard) and a comprehensive literature review of genetic focused mTBI research [PITH_FULL_IMAGE:figures/full_fig_p027_1.png] view at source ↗
Figure 3
Figure 3. Step three of the methodology was to investigate the GEO repository and download RNA-seq data associated with mTBI for mapping and differential expression analysis [PITH_FULL_IMAGE:figures/full_fig_p027_3.png] view at source ↗
Figure 7
Figure 7. The miRNAs were determined to be related to mTBIs and their predicted targets. These miRNAs show differential expression based on the BWA analysis. The mirsystem, mirwalk databases were used to predict target genes. miRNAs are shown with a red diamond, and genes are shown with a purple circle [PITH_FULL_IMAGE:figures/full_fig_p028_7.png] view at source ↗
Figures from the paper (6 more)
Figure 1
Figure 1. Figure 1 [PITH_FULL_IMAGE:figures/full_fig_p031_1.png]
Figure 2
Figure 2. Figure 2 [PITH_FULL_IMAGE:figures/full_fig_p031_2.png]
Figure 3
Figure 3. Figure 3 [PITH_FULL_IMAGE:figures/full_fig_p032_3.png]
Figure 6
Figure 6. Figure 6 [PITH_FULL_IMAGE:figures/full_fig_p033_6.png]
Figure 7
Figure 7. Figure 7 [PITH_FULL_IMAGE:figures/full_fig_p034_7.png]
Figure 1
Figure 1. Figure 1: FIG1.JPEG [PITH_FULL_IMAGE:figures/full_fig_p037_1.png]

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

97 extracted references · 69 canonical work pages

  1. [1]

    Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport–Amsterdam, October 2022

    Patricios JS, Schneider KJ, Dvorak J, Ahmed OH, Blauwet C, Cantu RC, Davis GA, Echemendia RJ, Makdissi M, McNamee M, et al. Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport–Amsterdam, October 2022. Br J Sports Med. 2023;57:695–711. doi: 10.1136/bjsports-2023-106898

  2. [2]

    Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae

    Pavlovic D, Pekic S, Stojanovic M, Popovic V. Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae. Pituitary. 2019;22:270–282. doi: 10.1007/s11102- 019-00957-9

  3. [3]

    Incidence, risk factors and prevention of mild traumatic brain injury: results of the who collaborating centre task force on mild traumatic brain injury

    Cassidy JD, Carroll L, Peloso P, Borg J, von Holst H, Holm L, Kraus J, Coronado V. Incidence, risk factors and prevention of mild traumatic brain injury: results of the who collaborating centre task force on mild traumatic brain injury. J Rehabil Med. 2004;36:28–60. doi: 10.1080/16501960410023732

  4. [4]

    Reports of Head Injury and Symptom Knowledge Among College Athletes: Implications for Assessment and Educational Intervention

    Kaut KP, DePompei R, Kerr J, Congeni J. Reports of Head Injury and Symptom Knowledge Among College Athletes: Implications for Assessment and Educational Intervention. Clinical Journal of Sport Medicine. 2003;13:213–221. doi: 10.1097/00042752-200307000-00004

  5. [5]

    Changing patterns in the epidemiology of traumatic brain injury

    Roozenbeek B, Maas AIR, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol [Internet]. 2013 [cited 2022 Nov 28];9:231–236. doi: 10.1038/NRNEUROL.2013.22. Cited: in: : PMID: 23443846

  6. [6]

    Sport-Related Concussion in Children and Adolescents

    Halstead ME, Walter KD, Moffatt K. Sport-Related Concussion in Children and Adolescents. Pediatrics [Internet]. 2018 [cited 2022 Nov 28];142. doi: 10.1542/PEDS.2018-3074. Cited: in: : PMID: 30420472

  7. [7]

    Concussion Symptom Profiles Among Child, Adolescent, and Young Adult Athletes

    Howell DR, Kriz P, Mannix RC, Kirchberg T, Master CL, Meehan WP. Concussion Symptom Profiles Among Child, Adolescent, and Young Adult Athletes. Clin J Sport Med [Internet]. 2019 [cited 2022 Nov 27];29:391–397. doi: 10.1097/JSM.0000000000000629. Cited: in: : PMID: 29933282

  8. [8]

    Concussion: A Global Perspective

    Hon KL, Leung AKC, Torres AR. Concussion: A Global Perspective. Semin Pediatr Neurol. 2019;30:117–127. doi: 10.1016/j.spen.2019.03.017

Show all 97 references
  1. [9]

    Symptoms at one year following concussion from minor head injuries

    Rutherford WH, Merrett JD, McDonald JR. Symptoms at one year following concussion from minor head injuries. Injury. 1979;10:225–230. doi: 10.1016/0020-1383(79)90015-9

  2. [10]

    Causes and Outcomes of Mild Traumatic Brain Injury: An Analysis of Ciren Data

    Dischinger P, Read K, Kerns T, Ho S, Kufera J, Burch C, Jawed N, Burgess A, Bents F. Causes and Outcomes of Mild Traumatic Brain Injury: An Analysis of Ciren Data. Annu Proc Assoc Adv Automot Med [Internet]. 2003 [cited 2022 Dec 10];47:577. Cited: in: : PMID: 12941252

  3. [11]

    Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury

    McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, Santini VE, Lee HS, Kubilus CA, Stern RA. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol [Internet]. 2009 [cited 2022 Dec 10];68:709–

  4. [12]

    Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma

    Baugh CM, Stamm JM, Riley DO, Gavett BE, Shenton ME, Lin A, Nowinski CJ, Cantu RC, McKee AC, Stern RA. Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging Behav. 2012;6:244–254. doi: 10.1007/s11682-0...

  5. [13]

    Self-Reported Head Injury and Risk of Late-Life Impairment and AD Pathology in an AD Center Cohort

    Abner EL, Nelson PT, Schmitt FA, Browning SR, Fardo DW, Wan L, Jicha GA, Cooper GE, Smith CD, Caban-Holt AM, et al. Self-Reported Head Injury and Risk of Late-Life Impairment and AD Pathology in an AD Center Cohort. Dement Geriatr Cogn Disord. 2014;37:294–306. doi: 10.1159/000355478

  6. [14]

    Biomechanics of Concussion

    Meaney DF, Smith DH. Biomechanics of Concussion. Clin Sports Med. 2011;30:19–31. doi: 10.1016/j.csm.2010.08.009

  7. [15]

    The Pathobiology of Traumatically Induced Axonal Injury in Animals and Humans: A Review of Current Thoughts

    POVLISHOCK JT, CHRISTMAN CW. The Pathobiology of Traumatically Induced Axonal Injury in Animals and Humans: A Review of Current Thoughts. J Neurotrauma. 1995;12:555–564. doi: 10.1089/neu.1995.12.555

  8. [16]

    A Possible Role for Integrin Signaling in Diffuse Axonal Injury

    Hemphill MA, Dabiri BE, Gabriele S, Kerscher L, Franck C, Goss JA, Alford PW, Parker KK. A Possible Role for Integrin Signaling in Diffuse Axonal Injury. PLoS One. 2011;6:e22899. doi: 10.1371/journal.pone.0022899

  9. [17]

    Classification of Traumatic Brain Injury for Targeted Therapies

    Saatman KE, Duhaime A-C, Bullock R, Maas AIR, Valadka A, Manley GT. Classification of Traumatic Brain Injury for Targeted Therapies. J Neurotrauma. 2008;25:719–738. doi: 10.1089/neu.2008.0586

  10. [18]

    Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies

    Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci. 2010;31:596–604. doi: 10.1016/j.tips.2010.09.005

  11. [19]

    Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

    Jarrahi A, Braun M, Ahluwalia M, Gupta R v., Wilson M, Munie S, Ahluwalia P, Vender JR, Vale FL, Dhandapani KM, et al. Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions. Biomedicines. 2020;8:389. doi: 10.3390/biomedicines8100389

  12. [20]

    A Review and Rationale for the Use of Genetically Engineered Animals in the Study of Traumatic Brain Injury

    Longhi L, Saatman KE, Raghupathi R, Laurer HL, Lenzlinger PM, Riess P, Neugebauer E, Trojanowski JQ, Lee VM-Y, Grady MS, et al. A Review and Rationale for the Use of Genetically Engineered Animals in the Study of Traumatic Brain Injury. Journal of Cerebral Blood Flow & Metabol...

  13. [21]

    A Review of the Molecular Mechanisms of Traumatic Brain Injury

    Ladak AA, Enam SA, Ibrahim MT. A Review of the Molecular Mechanisms of Traumatic Brain Injury. World Neurosurg. 2019;131:126–132. doi: 10.1016/j.wneu.2019.07.039

  14. [22]

    S100B Is an Important Outcome Predictor in Traumatic Brain Injury

    Thelin EP, Johannesson L, Nelson D, Bellander BM. S100B Is an Important Outcome Predictor in Traumatic Brain Injury. https://home.liebertpub.com/neu [Internet]. 2013 [cited 2022 Dec 11];30:519–528. doi: 10.1089/NEU.2012.2553. Cited: in: : PMID: 23297751

  15. [23]

    Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury

    Papa L, Brophy GM, Welch RD, Lewis LM, Braga CF, Tan CN, Ameli NJ, Lopez MA, Haeussler CA, Mendez Giordano DI, et al. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic...

  16. [24]

    Padgett CR, Summers MJ, Vickers JC, McCormack GH, Skilbeck CE. Exploring the effect of the apolipoprotein E (APOE) gene on executive function, working memory, and processing speed during the early recovery period following traumatic brain injury. https://doi.org/101080/1380339...

  17. [25]

    Post-traumatic brain injury: Genetic susceptibility to outcome

    Davidson J, Cusimano MD, Bendena WG. Post-traumatic brain injury: Genetic susceptibility to outcome. Neuroscientist [Internet]. 2015 [cited 2022 Dec 11];21:424–441. doi: 10.1177/1073858414543150/ASSET/IMAGES/LARGE/10.1177_1073858414543150-FIG1.JPEG. Cited: in: : PMID: 25059577

  18. [26]

    Systematic Review of Genetic Risk Factors for Sustaining a Mild Traumatic Brain Injury

    Panenka WJ, Gardner AJ, Dretsch MN, Crynen GC, Crawford FC, Iverson GL. Systematic Review of Genetic Risk Factors for Sustaining a Mild Traumatic Brain Injury. J Neurotrauma. 2017;34:2093–2099. doi: 10.1089/neu.2016.4833

  19. [27]

    The Role of BDNF in Experimental and Clinical Traumatic Brain Injury

    Gustafsson D, Klang A, Thams S, Rostami E. The Role of BDNF in Experimental and Clinical Traumatic Brain Injury. Int J Mol Sci. 2021;22:3582. doi: 10.3390/ijms22073582

  20. [28]

    Genetic Factors Modulating Outcome After Neurotrauma

    McAllister TW. Genetic Factors Modulating Outcome After Neurotrauma. PM&R. 2010;2:S241–S252. doi: 10.1016/j.pmrj.2010.10.005

  21. [29]

    Traumatic brain injuries

    Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, Yaffe K, Zetterberg H. Traumatic brain injuries. Nat Rev Dis Primers. 2016;2:16084. doi: 10.1038/nrdp.2016.84

  22. [30]

    Simpson E, Reiter JL, Ren J, Zhang Z, Nudelman KN, Riggen LD, Menser MD, Harezlak J, Foroud TM, Saykin AJ, et al. Gene Expression Alterations in Peripheral Blood Following Sport-Related Concussion in a Prospective Cohort of Collegiate Athletes: A Concussion Assessment, Researc...

  23. [31]

    MicroRNAs: small RNAs with a big role in gene regulation

    He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics 2004 5:7 [Internet]. 2004 [cited 2022 Dec 11];5:522–531. doi: 10.1038/nrg1379. Cited: in: : PMID: 15211354

  24. [32]

    The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis

    Liu J, Zhou F, Guan Y, Meng F, Zhao Z, Su Q, Bao W, Wang X, Zhao J, Huo Z, et al. The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis. Cells. 2022;11:572. doi: 10.3390/cells11030572

  25. [33]

    MicroRNAs

    Bartel DP. MicroRNAs. Cell. 2004;116:281–297. doi: 10.1016/S0092-8674(04)00045-5

  26. [34]

    Plasma micro-RNA biomarkers for diagnosis and prognosis after traumatic brain injury: A pilot study

    Mitra B, Rau TF, Surendran N, Brennan JH, Thaveenthiran P, Sorich E, Fitzgerald MC, Rosenfeld J v., Patel SA. Plasma micro-RNA biomarkers for diagnosis and prognosis after traumatic brain injury: A pilot study. Journal of Clinical Neuroscience. 2017;38:37–42. doi: 10.1016/J.JO...

  27. [35]

    MicroRNAs as Novel Biomarkers for the Diagnosis and Prognosis of Mild and Severe Traumatic Brain Injury

    Di Pietro V, Ragusa M, Davies D, Su Z, Hazeldine J, Lazzarino G, Hill LJ, Crombie N, Foster M, Purrello M, et al. MicroRNAs as Novel Biomarkers for the Diagnosis and Prognosis of Mild and Severe Traumatic Brain Injury. J Neurotrauma [Internet]. 2017 [cited 2022 Dec 7];34:1948–...

  28. [36]

    Bioinformatic analysis of brain-specific miRNAs for identification of candidate traumatic brain injury blood biomarkers

    O’Connell GC, Smothers CG, Winkelman C. Bioinformatic analysis of brain-specific miRNAs for identification of candidate traumatic brain injury blood biomarkers. Brain Inj. 2020;34:965–974. doi: 10.1080/02699052.2020.1764102

  29. [37]

    Consequences of Repeated Blood-Brain Barrier Disruption in Football Players

    Marchi N, Bazarian JJ, Puvenna V, Janigro M, Ghosh C, Zhong J, Zhu T, Blackman E, Stewart D, Ellis J, et al. Consequences of Repeated Blood-Brain Barrier Disruption in Football Players. PLoS One [Internet]. 2013 [cited 2022 Dec 4];8:e56805. doi: 10.1371/JOURNAL.PONE.0056805. C...

  30. [38]

    Extracellular microRNAs as messengers in the central and peripheral nervous system

    Scott H. Extracellular microRNAs as messengers in the central and peripheral nervous system. Neuronal Signal. 2017;1. doi: 10.1042/NS20170112

  31. [39]

    Serum exosomes miR-206 and miR-549a-3p as potential biomarkers of traumatic brain injury

    Yang Y, Wang Y, Li P, Bai F, Liu C, Huang X. Serum exosomes miR-206 and miR-549a-3p as potential biomarkers of traumatic brain injury. Sci Rep. 2024;14:10082. doi: 10.1038/s41598-024- 60827-8

  32. [40]

    Abnormal levels of expression of microRNAs in peripheral blood of patients with traumatic brain injury are induced by microglial activation and correlated with severity of injury

    Feng S, Wu Z, Zheng X, Shao Z, Lin Q, Sun S. Abnormal levels of expression of microRNAs in peripheral blood of patients with traumatic brain injury are induced by microglial activation and correlated with severity of injury. Eur J Med Res [Internet]. 2024 [cited 2025 Feb 20];2...

  33. [41]

    Gene expression patterns following unilateral traumatic brain injury reveals a local pro-inflammatory and remote anti- inflammatory response

    White TE, Ford GD, Surles-Zeigler MC, Gates AS, LaPlaca MC, Ford BD. Gene expression patterns following unilateral traumatic brain injury reveals a local pro-inflammatory and remote anti- inflammatory response. BMC Genomics [Internet]. 2013 [cited 2022 Dec 7];14:282. doi: 10.1...

  34. [42]

    Gene expression following traumatic brain injury in humans: analysis by microarray

    Michael DB, Byers DM, Irwin LN. Gene expression following traumatic brain injury in humans: analysis by microarray. Journal of Clinical Neuroscience. 2005;12:284–290. doi: 10.1016/j.jocn.2004.11.003

  35. [43]

    MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care

    di Pietro V, Yakoub KM, Scarpa U, di Pietro C, Belli A. MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care. Front Neurol. 2018;9. doi: 10.3389/fneur.2018.00429

  36. [44]

    Integrated Bioinformatics Analysis for the Identification of Key Molecules and Pathways in the Hippocampus of Rats After Traumatic Brain Injury

    Xiao X, Bai P, Cao S, Jiang Y, Liang W, Wang T, Luo X, Guan Q, Gao L, Zhang L. Integrated Bioinformatics Analysis for the Identification of Key Molecules and Pathways in the Hippocampus of Rats After Traumatic Brain Injury. Neurochem Res. 2020;45:928–939. doi: 10.1007/s11064- ...

  37. [45]

    Comparison of serum and saliva miRNAs for identification and characterization of mTBI in adult mixed martial arts fighters

    LaRocca D, Barns S, Hicks SD, Brindle A, Williams J, Uhlig R, Johnson P, Neville C, Middleton FA. Comparison of serum and saliva miRNAs for identification and characterization of mTBI in adult mixed martial arts fighters. PLoS One. 2019;14:e0207785. doi: 10.1371/journal.pone.0207785

  38. [46]

    A review of molecular and genetic factors for determining mild traumatic brain injury severity and recovery

    Tajik M, Danielli E, Sharma B, Noseworthy MD. A review of molecular and genetic factors for determining mild traumatic brain injury severity and recovery. Brain Disord. 2022;8:100058. doi: 10.1016/j.dscb.2022.100058

  39. [47]

    Gene Help: Integrated Access to Genes of Genomes in the Reference Sequence Collection

    Murphy M, Brown G, Wallin C. Gene Help: Integrated Access to Genes of Genomes in the Reference Sequence Collection. National Center for Biotechnology Information. 2006; 39

  40. [48]

    MalaCards: an integrated compendium for diseases and their annotation

    Rappaport N, Nativ N, Stelzer G, Twik M, Guan-Golan Y, Iny Stein T, Bahir I, Belinky F, Morrey CP, Safran M, et al. MalaCards: an integrated compendium for diseases and their annotation. Database. 2013;2013. doi: 10.1093/database/bat018

  41. [49]

    Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

    Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13. doi: 10.1093/nar/gkn923

  42. [50]

    Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

    Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. doi: 10.1038/nprot.2008.211

  43. [51]

    Gene Ontology: tool for the unification of biology

    Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene Ontology: tool for the unification of biology. Nature Genetics 2000 25:1 [Internet]. 2000 [cited 2022 Dec 12];25:25–29. doi: 10.1038/75556. Cited: in: : PMID...

  44. [52]

    KEGG: Kyoto Encyclopedia of Genes and Genomes

    Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27–30. doi: 10.1093/nar/28.1.27

  45. [53]

    Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

    Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Scienc...

  46. [54]

    STRING 8--a global view on proteins and their functional interactions in 630 organisms

    Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et al. STRING 8--a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009;37:D412–D416. doi: 10.1093/nar/gkn760

  47. [55]

    Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks

    Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003;13:2498–2504. doi: 10.1101/gr.1239303

  48. [56]

    cytoHubba: identifying hub objects and sub-networks from complex interactome

    Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11. doi: 10.1186/1752-0509-8- S4-S11

  49. [57]

    miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets

    Lu T-P, Lee C-Y, Tsai M-H, Chiu Y-C, Hsiao CK, Lai L-C, Chuang EY. miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets. PLoS One. 2012;7:e42390. doi: 10.1371/journal.pone.0042390

  50. [58]

    miRWalk: An online resource for prediction of microRNA binding sites

    Sticht C, de La Torre C, Parveen A, Gretz N. miRWalk: An online resource for prediction of microRNA binding sites. PLoS One [Internet]. 2018 [cited 2022 Dec 12];13:e0206239. doi: 10.1371/JOURNAL.PONE.0206239. Cited: in: : PMID: 30335862

  51. [59]

    miRmap web: comprehensive microRNA target prediction online

    Vejnar CE, Blum M, Zdobnov EM. miRmap web: comprehensive microRNA target prediction online. Nucleic Acids Res. 2013;41:W165–W168. doi: 10.1093/nar/gkt430

  52. [60]

    MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing

    Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing. Mol Cell. 2007;27:91–105. doi: 10.1016/j.molcel.2007.06.017. 40

  53. [61]

    miRDB: an online database for prediction of functional microRNA targets

    Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127–D131. doi: 10.1093/nar/gkz757

  54. [62]

    mirDIP 4.1— integrative database of human microRNA target predictions

    Tokar T, Pastrello C, Rossos AEM, Abovsky M, Hauschild A-C, Tsay M, Lu R, Jurisica I. mirDIP 4.1— integrative database of human microRNA target predictions. Nucleic Acids Res. 2018;46:D360– D370. doi: 10.1093/nar/gkx1144

  55. [63]

    DIANA-mirPath: Integrating human and mouse microRNAs in pathways

    Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics [Internet]. 2009 [cited 2022 Dec 12];25:1991–1993. doi: 10.1093/BIOINFORMATICS/BTP299. Cited: in: : PMID: 19435746

  56. [64]

    miRPathDB: a new dictionary on microRNAs and target pathways

    Backes C, Kehl T, Stöckel D, Fehlmann T, Schneider L, Meese E, Lenhof HP, Keller A. miRPathDB: a new dictionary on microRNAs and target pathways. Nucleic Acids Res [Internet]. 2017 [cited 2022 Dec 12];45:D90–D96. doi: 10.1093/NAR/GKW926. Cited: in: : PMID: 27742822

  57. [65]

    Investigating miRNA Expression in Athletes with Sport-Related Concussion

    Tomé GA. Investigating miRNA Expression in Athletes with Sport-Related Concussion. 2024

  58. [66]

    NCBI GEO: archive for functional genomics data sets—update

    Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res [Internet]. 2013 [cited 2022 Dec 12];41:D991. doi: 10.1093/NAR/GKS1193. C...

  59. [67]

    Trimmomatic: a flexible trimmer for Illumina sequence data

    Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics [Internet]. 2014 [cited 2022 Dec 12];30:2114–2120. doi: 10.1093/BIOINFORMATICS/BTU170. Cited: in: : PMID: 24695404

  60. [68]

    Fast and accurate short read alignment with Burrows-Wheeler transform

    Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–1760. doi: 10.1093/bioinformatics/btp324

  61. [69]

    A bioinformatics approach to microRNA-sequencing analysis

    Potla P, Ali SA, Kapoor M. A bioinformatics approach to microRNA-sequencing analysis. Osteoarthr Cartil Open. 2021;3:100131. doi: 10.1016/J.OCARTO.2020.100131

  62. [70]

    featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

    Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics [Internet]. 2014 [cited 2022 Dec 12];30:923–

  63. [71]

    miRBase: from microRNA sequences to function

    Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res [Internet]. 2019 [cited 2022 Dec 12];47:D155–D162. doi: 10.1093/NAR/GKY1141. Cited: in: : PMID: 30423142

  64. [72]

    The Sequence Alignment/Map format and SAMtools

    Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–2079. doi: 10.1093/bioinformatics/btp352

  65. [73]

    Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

    Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol [Internet]. 2014 [cited 2022 Dec 12];15:1–21. doi: 10.1186/S13059-014-0550-8/FIGURES/9. Cited: in: : PMID: 25516281. 41

  66. [74]

    Alcohol Health Res World

    The principles of nerve cell communication. Alcohol Health Res World. 1997;21:107–108. Cited: in: : PMID: 15704344

  67. [75]

    Molecular logic of neocortical projection neuron specification, development and diversity

    Greig LC, Woodworth MB, Galazo MJ, Padmanabhan H, Macklis JD. Molecular logic of neocortical projection neuron specification, development and diversity. Nat Rev Neurosci. 2013;14:755–769. doi: 10.1038/nrn3586

  68. [76]

    The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder

    Liu W, Zhang F, Zheng Y, He S, Zhang T, Guo Q, Xu H, Chen H, Liu C, Yu S, et al. The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder. Neurosci Lett. 2021;763:136184. doi: 10.1016/j.neulet...

  69. [77]

    Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease

    Gui Y, Liu H, Zhang L, Lv W, Hu X. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget. 2015;6:37043–37053. doi: 10.18632/oncotarget.6158

  70. [78]

    Long-Term Consequences: Effects on Normal Development Profile After Concussion

    Daneshvar DH, Riley DO, Nowinski CJ, McKee AC, Stern RA, Cantu RC. Long-Term Consequences: Effects on Normal Development Profile After Concussion. Phys Med Rehabil Clin N Am. 2011;22:683–700. doi: 10.1016/j.pmr.2011.08.009

  71. [79]

    Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder

    Forstner AJ, Hofmann A, Maaser A, Sumer S, Khudayberdiev S, Mühleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, et al. Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder. Transl Psychiatry. 2015;5:e678–e678. doi: ...

  72. [80]

    Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study

    Schneider R, McKeever P, Kim TH, Graff C, van Swieten JC, Karydas A, Boxer A, Rosen H, Miller BL, Laforce R, et al. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. J Neurol Neurosurg Psychiatry [Internet]. 2018 [cited 2022 Dec 14];89:85...

  73. [81]

    Extracellular Vesicle Proteins and MicroRNAs Are Linked to Chronic Post-Traumatic Stress Disorder Symptoms in Service Members and Veterans With Mild Traumatic Brain Injury

    Guedes VA, Lai C, Devoto C, Edwards KA, Mithani S, Sass D, Vorn R, Qu B-X, Rusch HL, Martin CA, et al. Extracellular Vesicle Proteins and MicroRNAs Are Linked to Chronic Post-Traumatic Stress Disorder Symptoms in Service Members and Veterans With Mild Traumatic Brain Injury. F...

  74. [82]

    MicroRNA sequencing of rat hippocampus and human biofluids identifies acute, chronic, focal and diffuse traumatic brain injuries

    Weisz HA, Kennedy D, Widen S, Spratt H, Sell SL, Bailey C, Sheffield-Moore M, DeWitt DS, Prough DS, Levin H, et al. MicroRNA sequencing of rat hippocampus and human biofluids identifies acute, chronic, focal and diffuse traumatic brain injuries. Sci Rep. 2020;10:3341. doi: 10....

  75. [83]

    Changes in circulating microRNAs following head impacts in soccer

    Sandmo SB, Matyasova K, Filipcik P, Cente M, Koerte IK, Pasternak O, Andersen TE, Straume- Næsheim TM, Bahr R, Jurisica I. Changes in circulating microRNAs following head impacts in soccer. Brain Inj [Internet]. 2022 [cited 2022 Dec 14];36:560–571. doi: 10.1080/02699052.2022.2...

  76. [84]

    miR-9 Upregulation Integrates Post-ischemic Neuronal Survival and Regeneration In Vitro

    Nampoothiri SS, Rajanikant GK. miR-9 Upregulation Integrates Post-ischemic Neuronal Survival and Regeneration In Vitro. Cell Mol Neurobiol. 2019;39:223–240. doi: 10.1007/s10571-018-0642- 1. 42

  77. [85]

    miR-9: A versatile regulator of neurogenesis

    Coolen M, Katz S, Bally-Cuif L. miR-9: A versatile regulator of neurogenesis. Front Cell Neurosci. 2013;7:220. doi: 10.3389/FNCEL.2013.00220/BIBTEX

  78. [86]

    Identification of miRNA Changes in Alzheimer’s Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

    Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, et al. Identification of miRNA Changes in Alzheimer’s Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways. Journal of Alzheimer’s Disease. 2008;1...

  79. [87]

    miR-15 and miR-16 induce apoptosis by targeting BCL2

    Cimmino A, Calin GA, Fabbri M, Iorio M v., Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A [Internet]. 2005 [cited 2022 Dec 14];102:13944–13949. doi: 10.1073/PNAS.0506654102/SUP...

  80. [88]

    Downregulation of microRNA-16-5p accelerates fracture healing by promoting proliferation and inhibiting apoptosis of osteoblasts in patients with traumatic brain injury

    Sun Y, Xiong Y, Yan C, Chen L, Chen D, Mi B, Liu G. Downregulation of microRNA-16-5p accelerates fracture healing by promoting proliferation and inhibiting apoptosis of osteoblasts in patients with traumatic brain injury. Am J Transl Res. 2019;11:4746–4760. Cited: in: : PMID: 31497196

  81. [89]

    Human Traumatic Brain Injury Alters Plasma microRNA Levels

    Redell JB, Moore AN, Ward NH, Hergenroeder GW, Dash PK. Human Traumatic Brain Injury Alters Plasma microRNA Levels. J Neurotrauma. 2010;27:2147–2156. doi: 10.1089/neu.2010.1481

  82. [90]

    Analysis of miRNA Expression Profiles in Traumatic Brain Injury (TBI) and Their Correlation with Survival and Severity of Injury

    Consalvo F, Padovano M, Scopetti M, Morena D, Cipolloni L, Fineschi V, Santurro A. Analysis of miRNA Expression Profiles in Traumatic Brain Injury (TBI) and Their Correlation with Survival and Severity of Injury. International Journal of Molecular Sciences 2024, Vol 25, Page 9...

  83. [91]

    RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke

    Tiedt S, Prestel M, Malik R, Schieferdecker N, Duering M, Kautzky V, Stoycheva I, Böck J, Northoff BH, Klein M, et al. RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke. Circ Res. 2017;121:970–980. doi: 10...

  84. [92]

    Bioinformatic analysis of a microRNA regulatory network in Huntington’s disease

    Wang Z-M, Dong X-Y, Cong S-Y. Bioinformatic analysis of a microRNA regulatory network in Huntington’s disease. J Integr Neurosci. 2020;19:641. doi: 10.31083/j.jin.2020.04.203

  85. [93]

    The transcriptional response of cortical neurons to concussion reveals divergent fates after injury

    Alkaslasi MR, Lloyd EYH, Gable AS, Silberberg H, Yarur HE, Tsai VS, Sohn M, Margolin G, Tejeda HA, Le Pichon CE. The transcriptional response of cortical neurons to concussion reveals divergent fates after injury. Nature Communications 2025 16:1 [Internet]. 2025 [cited 2025 Fe...

  86. [94]

    Salivary MicroRNAs: Diagnostic Markers of Mild Traumatic Brain Injury in Contact-Sport

    Di Pietro V, Porto E, Ragusa M, Barbagallo C, Davies D, Forcione M, Logan A, Di Pietro C, Purrello M, Grey M, et al. Salivary MicroRNAs: Diagnostic Markers of Mild Traumatic Brain Injury in Contact-Sport. Front Mol Neurosci [Internet]. 2018 [cited 2025 Feb 20];11:395270. doi: ...

  87. [95]

    Cell-Specific Gene Expressions Underlie Selective White Matter Loss Vulnerability in Mild Traumatic Brain Injury

    Jia X, Zhao W, Zhang H, Zhang X, Ji Q, Li X, Pan Y, Jiang X, Zhang J, Bai L. Cell-Specific Gene Expressions Underlie Selective White Matter Loss Vulnerability in Mild Traumatic Brain Injury. J Neurotrauma [Internet]. 2024 [cited 2025 Feb 20];42:118–130. doi: 10.1089/NEU.2024.0...

  88. [735]

    Cited: in: : PMID: 19535999

    doi: 10.1097/NEN.0B013E3181A9D503. Cited: in: : PMID: 19535999. 36

  89. [930]

    Cited: in: : PMID: 24227677

    doi: 10.1093/BIOINFORMATICS/BTT656. Cited: in: : PMID: 24227677

Pith tools

Reviewed August 16, 2026 · model on record in the stance chip above.